Powder: -20°C for 3 years
In solvent: -80°C for 2 years
XMD8-92 is an effective and specific BMK1/ERK5 inhibitor (Kd: 80 nM).
Description | XMD8-92 is an effective and specific BMK1/ERK5 inhibitor (Kd: 80 nM). |
Targets&IC50 | BMK1:80 nM(Kd) |
Kinase Assay | KiNativ profiling of XMD8-92 is carried out with both an ATP and ADP acylphosphate-desthiobiotin with the following modifications. HeLa cell lysates (5 mg/mL total protein) are incubated in the presence of XMD8-92 at 50 μM, 10 μM, 2 μM, 0.8 μM, and 0 μM for 15 minutes prior to addition of the ATP or ADP acylphosphate probe (5 μM final probe concentration). All reactions are performed in duplicate. Probe reactions proceeded for 10 minutes and the reaction stopped by the addition of urea and processed for MS analysis. Samples are analyzed by LC-MS/MS on a linear ion trap mass spectrometer using a time segmented "target list" designed to collect MS/MS spectra from all kinase peptide-probe conjugates that can be detected in HeLa cell lysates. This target list is generated and validated by prior exhaustive analysis of HeLa lysates. Up to four characteristic fragment ions for each kinase peptide-probe conjugate are used to extract signals for each kinase, and a comparison of inhibitor treated to control (untreated) lysates allow for precise determination of % inhibition at each point. A manuscript describing the details of this targeted mass spectrometry approach is in preparation[1]. |
Molecular Weight | 474.565 |
Formula | C26H30N6O3 |
CAS No. | 1234480-50-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 19 mg/mL (40 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
XMD8-92 1234480-50-2 DNA损伤和修复 MAPK信号通路 表观遗传 细胞周期 BMI-1 Epigenetic Reader Domain ERK Extracellular signal regulated kinases XMD-8-92 bFGF Inhibitor promyelocytic XMD8 92 protein cancer XMD892 inhibit leukemia HMEC inhibitor